High/JJ
Correlation/NN
between/IN
Alu/NN
Elements/NNS
and/CC
the/DT
Conversion/NN
of/IN
3/CD
’/NN
UTR/NN
of/IN
mRNAs/NNS
Processed/VBN
Pseudogenes/NNS
./.
====================
Even/RB
though/IN
it/PRP
represents/VBZ
6-13/CD
%/NN
of/IN
human/JJ
genomic/JJ
====================
DNA/NN
,/,
Alu/NNP
sequences/NNS
are/VBP
rarely/RB
found/VBN
in/IN
coding/VBG
regions/NNS
./.
====================
When/WRB
in/IN
exon/NN
region/NN
,/,
over/IN
80/CD
%/NN
of/IN
them/PRP
are/VBP
found/VBN
in/IN
3/CD
’/NN
untranslated/JJ
region/NN
(/(
UTR/NN
)/)
./.
====================
Pseudogenes/NNS
are/VBP
an/DT
important/JJ
component/NN
of/IN
human/JJ
genome/NN
./.
====================
Their/PRP$
functions/NNS
are/VBP
not/RB
clearly/RB
known/VBN
and/CC
the/DT
mechanism/NN
of/IN
how/WRB
they/PRP
are/VBP
generated/VBN
is/VBZ
still/RB
debatable/JJ
./.
====================
Both/DT
the/DT
Alu/NN
and/CC
Pseudogenes/NNS
are/VBP
important/JJ
research/NN
problems/VBZ
in/IN
molecular/JJ
biology/NN
./.
====================
mRNA/NN
is/VBZ
thought/VBN
to/TO
be/VB
a/DT
prime/JJ
source/NN
of/IN
pseudogene/NN
and/CC
active/JJ
research/NN
is/VBZ
going/VBG
on/IN
its/PRP$
molecular/JJ
mechanism/NN
./.
====================
We/PRP
report/VBP
,/,
for/IN
the/DT
first/JJ
time/NN
,/,
that/DT
mRNAs/NNS
containing/VBG
Alu/NNP
repeats/NNS
at/IN
3/CD
’/NN
UTR/NN
has/VBZ
a/DT
significantly/RB
high/JJ
correlation/NN
with/IN
processed/VBN
pseudogenes/NNS
,/,
suggesting/VBG
a/DT
possibility/NN
that/IN
Alu/NNP
containing/VBG
mRNAs/NNS
have/VBP
a/DT
high/JJ
tendency/NN
to/TO
become/VB
processed/VBN
pseudogenes/NNS
./.
====================
It/PRP
is/VBZ
known/VBN
that/IN
about/RB
10/CD
%/NN
of/IN
all/DT
human/JJ
genes/NNS
have/VBP
been/VBN
transposed/VBN
./.
====================
Transposed/VBN
genes/NNS
at/IN
3/CD
’/NN
UTR/NN
without/IN
Alu/NNP
repeat/NN
have/VBP
about/RB
two/CD
processed/VBN
pseudogenes/NNS
per/IN
gene/NN
on/IN
average/NN
while/IN
we/PRP
found/VBD
with/IN
statistical/JJ
significance/NN
that/IN
a/DT
transposed/VBN
gene/NN
with/IN
Alu/JJ
had/VBD
over/IN
three/CD
processed/VBN
Pseudogenes/NNS
on/IN
average/NN
./.
====================
Therefore/RB
,/,
we/PRP
propose/VBP
Alu/IN
repeats/NNS
as/IN
a/DT
new/JJ
and/CC
important/JJ
factor/NN
in/IN
the/DT
generation/NN
of/IN
pseudogenes/NNS
./.
====================
Alu/RB
elements/NNS
have/VBP
been/VBN
amplified/VBN
in/IN
primate/JJ
genomes/NNS
through/IN
an/DT
RNA-dependent/JJ
mechanism/NN
,/,
termed/VBN
retro-/JJ
transposition/NN
,/,
and/CC
have/VBP
reached/VBN
a/DT
copy/NN
number/NN
in/IN
excess/NN
====================
of/IN
500,000/CD
copies/NNS
per/FW
human/JJ
genome/NN
(/(
Deininger/NNP
et/FW
al./FW
,/,
1999/CD
)/)
./.
====================
Alu/RB
sequences/NNS
represent/VBP
around/IN
6-13/CD
%/NN
of/IN
human/JJ
genomic/JJ
DNA/NN
(/(
Mighell/NN
et/FW
al./FW
,/,
1997/CD
;/:
Boeke/NNP
1997/CD
)/)
./.
====================
Alu/RB
sequences/NNS
were/VBD
identified/VBN
in/IN
5/CD
%/NN
of/IN
1616/CD
human/JJ
full-/JJ
length/NN
cDNA/NN
,/,
82/CD
%/NN
of/IN
which/WDT
were/VBD
found/VBN
in/IN
the/DT
3/CD
’/NN
UTR/NN
,/,
14/CD
%/NN
lie/VBP
in/IN
the/DT
5/CD
’/NN
UTR/NN
,/,
and/CC
very/RB
rarely/RB
in/IN
coding/VBG
region/NN
(/(
Yulung/NN
et/FW
al./FW
,/,
1995/CD
)/)
./.
====================
Alu/RB
sequences/NNS
are/VBP
postulated/VBN
to/TO
be/VB
retrotransposon/NN
that/DT
have/VBP
been/VBN
inserted/VBN
into/IN
the/DT
human/JJ
genome/NN
via/IN
a/DT
single-stranded/JJ
RNA/NN
generated/VBN
by/IN
RNA/NN
polymerase/NN
III/CD
transcription/NN
,/,
but/CC
the/DT
mechanisms/NNS
and/CC
factors/NNS
about/RB
retrotransposition/NN
are/VBP
very/RB
poorly/RB
understood/VBN
(/(
Mighell/NN
et/FW
al./FW
,/,
1997/CD
;/:
Moran/NNP
etal./FW
,/,
1999/CD
)/)
./.
====================
Pseudogenes/NNS
are/VBP
regarded/VBN
as/IN
disabled/VBN
copies/NNS
of/IN
genes/NNS
that/WDT
are/VBP
known/VBN
to/TO
have/VB
no/DT
important/JJ
function/NN
and/CC
do/VBP
not/RB
code/VB
any/DT
full-length/JJ
proteins/NNS
./.
====================
Pseudogenes/NNS
are/VBP
known/VBN
to/TO
be/VB
a/DT
consequence/NN
of/IN
gene/NN
duplication/NN
which/WDT
====================
can/MD
occur/VB
in/IN
two/CD
fundamentally/RB
different/JJ
ways/NNS
:/:
firstly/RB
,/,
by/IN
retrotransposition/NN
,/,
and/CC
secondly/RB
,/,
via/IN
the/DT
duplication/NN
of/IN
genomic/JJ
DNA/NN
./.
====================
Pseudogenes/NNS
occurred/VBD
by/IN
retrotransposition/NN
are/VBP
known/VBN
as/IN
processed/VBN
pseudogenes/NNS
(/(
Maestre/NN
et/FW
al./FW
,/,
1955/CD
;/:
Mighell/NN
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
Human/JJ
pseudogenes/NNS
on/IN
chromosome/NN
21/CD
and/CC
22/CD
first/JJ
had/VBD
been/VBN
discovered/VBN
by/IN
Gerstein/NN
group/NN
in/IN
USA/NN
(/(
Harrison/NN
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
Over/RB
8,000/CD
====================
processed/VBN
pseudogenes/NNS
of/IN
human/JJ
were/VBD
identified/VBN
by/IN
the/DT
same/JJ
group/NN
./.
====================
20/CD
%/NN
of/IN
processed/VBN
pseudogenes/NNS
are/VBP
from/IN
highly/RB
expressed/VBN
ribosomal/JJ
proteins/NNS
and/CC
about/IN
10/CD
%/NN
of/IN
genes/NNS
are/VBP
known/VBN
to/TO
be/VB
originated/VBN
in/IN
the/DT
discovered/JJ
processed/VBN
pseudogenes/NNS
./.
====================
There/EX
are/VBP
three/CD
factors/NNS
affecting/VBG
biogenesis/NN
of/IN
processed/VBN
pseudogenes/NNS
./.
====================
First/RB
,/,
mRNA/NN
expression/NN
level/NN
is/VBZ
the/DT
most/JJS
deciding/VBG
factor/NN
./.
====================
Higher/JJ
number/NN
of/IN
mRNA/NN
transcripts/NNS
in/IN
the/DT
germ-line/NN
cell/NN
is/VBZ
proportional/JJ
to/TO
the/DT
higher/JJR
chance/NN
of/IN
retrotransposition/NN
compared/VBN
to/TO
those/DT
genes/NNS
that/WDT
are/VBP
less/RBR
well/RB
transcribed/VBN
./.
====================
Second/RB
,/,
relatively/RB
GC/NN
poor/JJ
ribosomal/JJ
protein/NN
(/(
RP/NN
)/)
genes/NNS
have/VBP
more/RBR
processed/VBN
pseudogenes/NNS
than/IN
GC-rich/JJ
RP/NN
genes/NNS
./.
====================
Third/RB
,/,
the/DT
reverse-transcription/NN
and/CC
insertion/NN
processes/NNS
are/VBP
less/RBR
efficient/JJ
for/IN
longer/RBR
mRNA/NN
transcripts/NNS
than/IN
shorter/JJR
mRNA/NN
transcripts/NNS
(/(
Zhang/NNP
and/CC
Madden/JJ
2003/CD
)/)
./.
====================
Long/JJ
Interspersed/JJ
Nucleotide/JJ
Element/JJ
(/(
LINE/NN
)/)
has/VBZ
a/DT
few/JJ
functions/NNS
in/IN
human/JJ
./.
====================
For/IN
examples/NNS
,/,
autonomous/JJ
retrotransposons/NNS
,/,
processed/VBN
pseudogene/NN
formation/NN
,/,
exon/NN
shuffling/VBG
and/CC
double-strand-break/JJ
repair/NN
(/(
Moran/NNP
et/FW
al./FW
,/,
2001/CD
;/:
Ostertag/NN
and/CC
Kazazian/JJ
,/,
2001/CD
;/:
Kazazian/JJ
and/CC
Goodier/NN
,/,
2002/CD
)/)
./.
====================
Both/DT
Alu/NNP
and/CC
mRNAs/NNS
are/VBP
transposed/VBN
by/IN
the/DT
products/NNS
of/IN
LINE/NN
because/IN
the/DT
products/NNS
bind/VBP
to/TO
polyA/NN
of/IN
not/RB
only/RB
LINE/NN
,/,
but/CC
also/RB
mRNAs/NNS
and/CC
Alu/FW
./.
====================
Although/IN
the/DT
mechanisms/NNS
of/IN
transposition/NN
of/IN
both/DT
of/IN
Alu/JJ
and/CC
mRNAs/NNS
are/VBP
the/DT
same/JJ
,/,
the/DT
efficiency/NN
of/IN
the/DT
transpositions/NNS
of/IN
Alu/JJ
is/VBZ
over/IN
300/CD
times/NNS
higher/JJR
than/IN
that/DT
of/IN
mRNA/NN
(/(
Esnault/NN
et/FW
al./FW
,/,
2000/CD
;/:
Kazazian/JJ
,/,
2004/CD
)/)
./.
====================
The/DT
signal/NN
recognition/NN
particle/NN
(/(
SRP/NN
)/)
binding/NN
to/TO
Alu/JJ
RNA/NN
brings/NNS
the/DT
Alu/NN
RNA/NN
into/IN
proximity/NN
with/IN
ribosomes/NNS
and/CC
nascent/JJ
L1/NN
proteins/NNS
on/IN
L1/NN
RNA/NN
(/(
Dewannieux/NN
et/FW
al./FW
,/,
2003/CD
;/:
Kazazian/JJ
,/,
2004/CD
)/)
./.
====================
This/DT
particle/NN
has/VBZ
been/VBN
known/VBN
as/IN
the/DT
factor/NN
of/IN
increasing/VBG
the/DT
efficiency/NN
of/IN
transposition/NN
of/IN
Alu/NN
./.
====================
This/DT
study/NN
reports/VBZ
a/DT
correlation/NN
between/IN
Alu/NNP
that/DT
are/VBP
included/VBN
in/IN
the/DT
3/CD
’/NN
UTR/NN
of/IN
mRNAs/NNS
and/CC
the/DT
production/NN
of/IN
processed/VBN
pseudogenes/NNS
./.
====================
We/PRP
support/VBP
that/DT
hypothesis/NN
that/IN
Alu/NN
can/MD
enhance/VB
the/DT
conversion/NN
of/IN
mRNA/NN
into/IN
processed/VBN
pseudogenes/NNS
./.
====================
The/DT
list/NN
of/IN
processed/VBN
pseudogenes/NNS
was/VBD
downloaded/VBN
in/IN
====================
the/DT
website/JJ
(/(
http/NN
:/:
//www.pseudogene.org//JJ
)/)
./.
====================
\Ne/DT
removed/VBD
about/RB
2,000/CD
processed/VBN
pseudogenes/NNS
originated/VBN
from/IN
ribosomal/JJ
proteins/NNS
among/IN
all/DT
the/DT
8,000/CD
processed/VBN
Pseudogenes/NNS
./.
====================
This/DT
is/VBZ
because/IN
we/PRP
only/RB
consider/VBP
mRNA/NN
sequences/NNS
./.
====================
The/DT
list/NN
was/VBD
published/VBN
in/IN
the/DT
human/JJ
genome/NN
draft/NN
build/JJ
34/CD
./.
====================
Blastn/NN
program/NN
of/IN
NCBI/NN
was/VBD
used/VBN
to/TO
match/VB
processed/VBN
pseudogene/NN
sequences/NNS
and/CC
the/DT
sequences/NNS
in/IN
the/DT
human/JJ
chromosome/NN
./.
====================
The/DT
reference/NN
sequences/NNS
(/(
RefSeq/NN
)/)
of/IN
NCBI/NN
are/VBP
reviewed/VBN
sequences/NNS
that/WDT
are/VBP
more/RBR
reliable/JJ
than/IN
most/JJS
other/JJ
databases/NNS
====================
(/(
ftp/NN
:/:
//ftp/JJ
./.
====================
ncbi/RB
./.
====================
nih/DT
./.
====================
gov/refseq/H_sapiens/mRNA_Prot/RB
)/)
./.
====================
The/DT
IDs/NNS
of/IN
processed/VBN
pseudogenes/NNS
are/VBP
named/VBN
after/IN
SwissProt/JJ
(/(
http/NN
:/:
//www.expasy.org//JJ
)/)
IDs/NNS
./.
====================
We/PRP
searched/VBD
for/IN
the/DT
original/JJ
mRNA/NN
sequences/NNS
of/IN
processed/VBN
pseudogenes/NNS
by/IN
mapping/VBG
IDs/NNS
between/IN
RefSeq/NN
IDs/NNS
and/CC
SwissProt/NN
IDs/NNS
in/IN
the/DT
website/JJ
;/:
GeneCard/NNP
(/(
http/NN
:/:
//bioinformatics.weizmann/JJ
./.
====================
ac.il/cards//IN
)/)
./.
====================
881/CD
mRNA/NN
sequences/NNS
were/VBD
matched/VBN
to/TO
2150/CD
processed/VBN
pseudogenes/NNS
./.
====================
In/IN
previous/JJ
studies/NNS
,/,
processed/VBN
pseudogenes/NNS
were/VBD
searched/VBN
against/IN
only/RB
the/DT
protein/NN
coding/VBG
regions/NNS
and/CC
their/PRP$
UTRs/NNS
(/(
untranslated/JJ
region/NN
)/)
were/VBD
not/RB
considered/VBN
as/IN
they/PRP
converted/VBD
protein/NN
sequences/NNS
to/TO
DNA/NN
sequences/NNS
as/IN
data/NNS
source/VBP
./.
====================
However/RB
,/,
as/IN
most/JJS
of/IN
Alu/JJ
sequences/NNS
in/IN
mRNAs/NNS
are/VBP
in/IN
the/DT
3/CD
’/NN
UTR/NN
region/NN
,/,
we/PRP
chose/VBP
to/TO
use/VB
3/CD
’/NN
UTR/NN
sequences/NNS
of/IN
mRNAs/NNS
from/IN
RefSeq/NN
./.
====================
The/DT
same/JJ
protocol/NN
was/VBD
applied/VBN
to/TO
the/DT
processed/VBN
Pseudogenes/NNS
for/IN
the/DT
3/CD
’/NN
UTR/NN
sequence/NN
regions/NNS
./.
====================
Additionally/RB
,/,
for/IN
higher/JJR
quality/NN
data/NNS
,/,
we/PRP
removed/VBD
3/CD
’/NN
UTR/NN
sequences/NNS
that/WDT
were/VBD
not/RB
alignable/JJ
from/IN
the/DT
RefSeq/NN
and/CC
processed/VBN
pseudogenes/NNS
./.
====================
The/DT
reason/NN
why/WRB
there/EX
are/VBP
unalignable/JJ
sequences/NNS
between/IN
the/DT
two/CD
sets/NNS
(/(
RefSeq/NN
derived/VBN
and/CC
processed/VBN
Pseudogenes/NNS
)/)
is/VBZ
that/DT
there/EX
could/MD
have/VB
been/VBN
deletions/NNS
at/IN
3/CD
’/NN
UTR/NN
of/IN
pseudogenes/NNS
for/IN
the/DT
last/JJ
few/JJ
hundred/VBD
thousand/CC
years/NNS
./.
====================
The/DT
final/JJ
dataset/NN
had/VBD
1214/CD
processed/VBN
pseudogenes/NNS
covered/VBD
by/IN
581/CD
mRNA/NN
species/NNS
./.
====================
The/DT
following/VBG
are/VBP
the/DT
stepwise/JJ
summary/NN
of/IN
the/DT
====================
procedure/NN
:/:
====================
1/CD
)/)
RefSeq/NN
consisted/VBD
of/IN
about/RB
20,000/CD
mRNA/NN
sequences/NNS
and/CC
processed/VBN
pseudogenes/NNS
were/VBD
about/RB
6,000/CD
sequences/NNS
excluding/VBG
2,000/CD
originated/VBN
from/IN
ribosomal/JJ
proteins/NNS
./.
====================
2/CD
)/)
About/RB
10/CD
%/NN
of/IN
RefSeq/NN
mRNAs/NNS
contain/VBP
20,000/CD
processed/VBN
pseudogenes/NNS
./.
====================
It/PRP
is/VBZ
consistent/JJ
with/IN
the/DT
previous/JJ
study/NN
(/(
Zhang/NNP
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
The/DT
pseudogene/NN
database/NN
had/VBD
only/RB
Swissprot/NN
IDs/NNS
(/(
e.g/FW
./.
====================
chr2_O75317.1/NN
,/,
chrY_O75317.1/NN
,/,
and/CC
chrX_O75317.1/NN
)/)
,/,
however/RB
,/,
The/DT
Genbank/NN
format/IN
of/IN
RefSeq/NN
had/VBD
no/DT
Swissprot/JJ
IDs/NNS
./.
====================
Therefore/RB
,/,
we/PRP
make/VBP
the/DT
simple/JJ
java/NN
source/NN
that/DT
compared/VBN
Swissprot/NN
IDs/NNS
with/IN
RefSeq/NN
IDs/NNS
in/IN
the/DT
the/DT
wabsite/NN
;/:
GeneCard/NNP
(/(
http/NN
:/:
//bioinformatics.weizmann.ac.il/cards//JJ
)/)
./.
====================
As/IN
a/DT
result/NN
,/,
881/CD
out/RP
of/IN
2,000/CD
RefSeq/NN
IDs/NNS
were/VBD
matched/VBN
with/IN
2,150/CD
out/RP
of/IN
about/RB
6,000/CD
./.
====================
3/CD
)/)
881/CD
out/RP
of/IN
2,000/CD
mRNAs/NNS
contained/VBD
2150/CD
pseudogenes/NNS
(/(
on/IN
average/NN
2.4/CD
pseudogenes/NNS
per/FW
mRNA/NN
)/)
====================
4/CD
)/)
We/PRP
collected/VBD
3/CD
’/NN
UTR/NN
sequences/NNS
of/IN
both/DT
mRNAs/NNS
and/CC
pseudogenes/NNS
with/IN
annotation/NN
information/NN
of/IN
RefSeq/NN
./.
====================
5/CD
)/)
Sequence/NN
alignment/NN
with/IN
bl2seq/NN
program/NN
(/(
from/IN
====================
NCBI/NN
)/)
for/IN
quality/NN
checking/VBG
./.
====================
6/CD
)/)
If/IN
there/EX
are/VBP
no/DT
matching/VBG
regions/NNS
between/IN
the/DT
two/CD
3/CD
’/NN
UTR/NN
sequences/NNS
,/,
we/PRP
removed/VBD
the/DT
3/CD
’/NN
UTRs/NNS
from/IN
the/DT
mRNA/NN
and/CC
pseudogene/NN
data/NNS
sets/NNS
./.
====================
When/WRB
pseudogenes/NNS
were/VBD
discovered/VBN
and/CC
published/VBN
,/,
the/DT
length/NN
criterion/NN
of/IN
them/PRP
was/VBD
70/CD
%/NN
of/IN
the/DT
length/NN
of/IN
original/JJ
genes/NNS
./.
====================
If/IN
3/CD
’/NN
sequence/NN
of/IN
pseudogene/NN
was/VBD
truncated/VBN
,/,
the/DT
pseudogene/NN
had/VBD
no/DT
3/CD
’/NN
UTR/NN
;/:
therefore/RB
,/,
we/PRP
made/VBD
an/DT
alignment/NN
between/IN
3/CD
’/NN
UTR/NN
of/IN
mRNA/NN
and/CC
that/IN
of/IN
pseudogenes/NNS
./.
====================
In/IN
this/DT
process/NN
,/,
====================
300/CD
mRNAs/NNS
containing/VBG
936/CD
pseudogenes/NNS
were/VBD
excluded/VBN
(/(
resulting/VBG
in/IN
581/CD
mRNAs/NNS
)/)
./.
====================
7/CD
)/)
Finally/RB
,/,
581/CD
mRNAs/NNS
and/CC
1214/CD
pseudogenes/NNS
were/VBD
in/IN
our/PRP$
dataset/NN
(/(
on/IN
average/NN
2.09/CD
pseudogenes/NNS
per/FW
mRNA/NN
)/)
====================
518/CD
mRNAs/NNS
had/VBD
2.09/CD
processed/VBN
pseudogenes/NNS
on/IN
average/JJ
and/CC
37/CD
mRNAs/NNS
(/(
n/NN
)/)
with/IN
Alu/NNP
at/IN
3/CD
’/NN
UTR/NN
mRNAs/NNS
had/VBD
3.11/CD
pseudogenes/NNS
on/IN
average/JJ
;/:
therefore/RB
,/,
the/DT
average/JJ
of/IN
the/DT
population/NN
of/IN
whole/JJ
mRNAs/NNS
was/VBD
2.09/CD
(/(
u/FW
)/)
,/,
and/CC
the/DT
average/JJ
of/IN
the/DT
population/NN
of/IN
mRNAs/NNS
with/IN
Alu/NNP
is/VBZ
3.11/CD
(/(
X/NN
)/)
./.
====================
And/CC
also/RB
,/,
the/DT
standard/JJ
deviation/NN
of/IN
the/DT
====================
population/NN
was/VBD
3.32/CD
among/IN
518/CD
whole/JJ
mRNAs/NNS
./.
====================
Therefore/RB
,/,
P/NN
value/NN
was/VBD
0.0336/CD
./.
====================
9.5/CD
%/NN
of/IN
processed/VBN
pseudogenes/NNS
had/VBD
Alu/RB
repeats/NNS
,/,
but/CC
6.4/CD
%/NN
of/IN
mRNAs/NNS
of/IN
reference/NN
sequences/NNS
(/(
RefSeq/NN
)/)
supported/VBD
by/IN
National/JJ
Center/JJ
for/IN
Biotechnology/NN
Information/NN
(/(
NCBI/NN
)/)
had/VBD
Alu/RB
over/IN
100/CD
bases/NNS
at/IN
3/CD
’/NN
UTR/NN
in/IN
our/PRP$
dataset/NN
(/(
see/VB
Methods/NNS
)/)
./.
====================
The/DT
average/JJ
length/NN
of/IN
Alu/JJ
is/VBZ
known/VBN
to/TO
be/VB
about/RB
280bp/RB
and/CC
the/DT
previous/JJ
study/NN
used/VBD
the/DT
minimum/JJ
length/NN
of/IN
Alu/JJ
as/IN
around/IN
60bp/JJ
and/CC
the/DT
minimum/JJ
of/IN
70/CD
%/NN
identity/NN
(/(
Weiner/NN
etal./FW
,/,
1986/CD
;/:
Yulung/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
In/IN
our/PRP$
study/NN
,/,
we/PRP
set/VBP
a/DT
more/RBR
rigorous/JJ
threshold/NN
of/IN
100bp/JJ
and/CC
70/CD
%/NN
identity/NN
./.
====================
We/PRP
found/VBD
that/IN
there/EX
were/VBD
few/JJ
Alu/NNP
at/IN
5/CD
’/NN
UTR/NN
in/IN
both/DT
mRNAs/NNS
and/CC
the/DT
processed/VBN
pseudogenes/NNS
because/IN
of/IN
short/JJ
lengths/NNS
of/IN
5/CD
’/NN
UTRs/NNS
(/(
Table/JJ
1/CD
)/)
and/CC
it/PRP
is/VBZ
consistent/JJ
with/IN
a/DT
previous/JJ
study/NN
(/(
Yulung/NN
et/FW
al./FW
,/,
1995/CD
)/)
./.
====================
On/IN
average/NN
an/DT
mRNA/NN
had/VBD
2.09/CD
processed/VBN
====================
pseudogenes/NNS
in/IN
our/PRP$
dataset/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
an/DT
mRNAs/NNS
without/IN
Alu/NNP
at/IN
3/CD
’/NN
UTR/NN
had/VBD
2.02/CD
processed/VBN
pseudogenes/NNS
and/CC
3.11/CD
processed/VBN
pseudogenes/NNS
on/IN
average/NN
per/IN
mRNA/NN
with/IN
Alu/JJ
at/IN
3/CD
’/NN
UTR/NN
(/(
Z=1.83/NN
,/,
P/NN
</JJR
0.034/CD
)/)
./.
====================
We/PRP
have/VBP
selected/VBN
30/CD
random/JJ
mRNAs/NNS
for/IN
each/DT
data/NNS
set/VBP
from/IN
two/CD
types/NNS
of/IN
data/NNS
;/:
one/CD
containing/VBG
Alu/NN
and/CC
the/DT
====================
other/JJ
not-containing/JJ
Alu/NN
at/IN
3/CD
’/NN
UTR/NN
./.
====================
The/DT
reason/NN
for/IN
selecting/VBG
30/CD
randomly/RB
generated/VBN
mRNA/NN
was/VBD
for/IN
a/DT
comparison/NN
under/IN
same/JJ
conditions/NNS
./.
====================
These/DT
random/JJ
mRNAs/NNS
removed/VBD
possible/JJ
bias/NNS
due/JJ
to/TO
one/CD
or/CC
two/CD
mRNAs/NNS
containing/VBG
a/DT
great/JJ
number/NN
of/IN
pseudogenes/NNS
./.
====================
If/IN
our/PRP$
result/NN
was/VBD
due/JJ
to/TO
such/JJ
bias/IN
by/IN
mRNAs/NNS
containing/VBG
a/DT
great/JJ
number/NN
of/IN
pseudogenes/NNS
,/,
normal/JJ
distribution/NN
like/IN
Figure/NN
1/CD
would/MD
not/RB
be/VB
shown/VBN
and/CC
the/DT
bias/NNS
would/MD
be/VB
detected/VBN
in/IN
the/DT
distribution/NN
statistics/NNS
./.
====================
I.e./FW
,/,
Figure/NN
1/CD
showed/VBD
that/IN
there/EX
is/VBZ
no/DT
such/JJ
bias/NNS
by/IN
unusually/RB
high/JJ
number/NN
of/IN
Pseudogenes/NNS
./.
====================
The/DT
random/JJ
sampling/JJ
process/NN
has/VBZ
been/VBN
iterated/VBN
500/CD
times/NNS
to/TO
eliminate/VB
statistical/JJ
bias/NNS
./.
====================
We/PRP
compared/VBD
the/DT
randomly/RB
generated/VBN
mRNAs/NNS
between/IN
two/CD
data/NNS
sets/NNS
./.
====================
The/DT
distribution/NN
of/IN
the/DT
numbers/NNS
of/IN
Pseudogenes/NNS
in/IN
the/DT
randomly/RB
generated/VBN
sets/NNS
of/IN
mRNAs/NNS
is/VBZ
shown/VBN
in/IN
Figure/NN
1/CD
./.
====================
The/DT
mRNAs/NNS
containing/VBG
Alu/NNP
at/IN
3/CD
’/NN
UTR/NN
had/VBD
at/IN
most/JJS
80-100/CD
processed/VBN
pseudogenes/NNS
while/IN
40-60/CD
processed/VBN
pseudogenes/NNS
were/VBD
found/VBN
in/IN
the/DT
mRNAs/NNS
that/IN
do/VBP
not/RB
contain/VB
out/RP
of/IN
500/CD
randomly/RB
sampled/JJ
====================
repeats/NNS
./.
====================
As/IN
shown/VBN
in/IN
the/DT
distribution/NN
,/,
in/IN
the/DT
range/NN
of/IN
40/CD
to/TO
100/CD
pseudogene/NN
copies/NNS
in/IN
the/DT
X-axis/NN
,/,
the/DT
number/NN
of/IN
pseudogenes/NNS
without/IN
Alu/NNP
decreases/VBZ
,/,
but/CC
the/DT
number/NN
of/IN
those/DT
with/IN
Alu/JJ
increases/VBZ
./.
====================
After/IN
around/IN
100/CD
pseudogene/NN
copies/NNS
,/,
there/EX
are/VBP
few/JJ
processed/VBN
pseudogene/NN
without/IN
Alu/NNP
at/IN
3/CD
’/NN
UTR/NN
while/IN
the/DT
number/NN
of/IN
processed/VBN
pseudogenes/NNS
with/IN
Alu/JJ
at/IN
3/CD
’/NN
UTR/NN
rises/NNS
to/TO
200/CD
pseudogenes/NNS
copies/NNS
./.
====================
Alu/RB
is/VBZ
one/CD
of/IN
the/DT
representative/JJ
transposons/NNS
in/IN
human/JJ
genome/NN
./.
====================
Alu/RB
sequences/NNS
are/VBP
known/VBN
to/TO
be/VB
randomly/RB
inserted/VBN
in/IN
human/JJ
genome/NN
./.
====================
Some/DT
of/IN
them/PRP
are/VBP
located/JJ
in/IN
UTR/NN
and/CC
are/VBP
transcribed/VBN
with/IN
the/DT
host/NN
mRNAs/NNS
containing/VBG
the/DT
Alu/NN
repeats/NNS
./.
====================
The/DT
transposition/NN
of/IN
Alu/JJ
element/NN
is/VBZ
known/VBN
to/TO
be/VB
300/CD
times/NNS
more/RBR
efficient/JJ
(/(
Dewannieux/NNP
et/FW
al./FW
,/,
2003/CD
)/)
on/IN
average/NN
than/IN
that/DT
of/IN
any/DT
mRNAs/NNS
because/IN
SRP/NN
binding/VBG
at/IN
Alu/NNP
is/VBZ
suggested/VBN
to/TO
bring/VBG
itself/PRP
into/IN
ribosome/NN
and/CC
in/IN
the/DT
vicinity/NN
of/IN
the/DT
products/NNS
of/IN
LINE/NN
./.
====================
We/PRP
suspected/VBD
that/DT
the/DT
Alu/NN
within/IN
mRNA/NN
had/VBD
a/DT
similar/JJ
effect/NN
as/IN
Alu/RB
alone/RB
./.
====================
It/PRP
is/VBZ
also/RB
suggested/VBD
that/IN
once/RB
Alu/NNP
is/VBZ
inserted/VBN
in/IN
human/JJ
genome/NN
,/,
stays/VBZ
in/IN
the/DT
genome/NN
except/IN
in/IN
the/DT
case/NN
of/IN
homologous/JJ
recombination/NN
mechanism/NN
(/(
Lander/NN
etal./FW
,/,
2001/CD
;/:
Kazazian/JJ
,/,
2004/CD
and/CC
personal/JJ
communication/NN
)/)
./.
====================
Therefore/RB
,/,
most/JJS
processed/VBN
Pseudogenes/NNS
should/MD
have/VBP
the/DT
same/JJ
tract/NN
of/IN
Alu/NN
as/IN
that/DT
of/IN
the/DT
original/JJ
functional/JJ
genes/NNS
./.
====================
This/DT
tendency/NN
of/IN
stable/JJ
preservation/NN
of/IN
Alu/JJ
is/VBZ
the/DT
foundation/NN
of/IN
our/PRP$
experiment/NN
in/IN
calculating/JJ
the/DT
tendency/NN
of/IN
pseudogene/NN
generation/NN
when/WRB
Alu/FW
sequences/NNS
are/VBP
inserted/VBN
in/IN
mRNA/NN
./.
====================
Few/JJ
Alu/NNP
repeats/NNS
at/IN
5/CD
’/NN
UTR/NN
were/VBD
found/VBN
in/IN
our/PRP$
study/NN
,/,
and/CC
it/PRP
is/VBZ
consistent/JJ
with/IN
previous/JJ
survey/NN
(/(
Yulung/NN
et/FW
al./FW
,/,
1995/CD
)/)
./.
====================
This/DT
is/VBZ
mainly/RB
because/IN
the/DT
length/NN
of/IN
5/CD
’/NN
UTR/NN
is/VBZ
much/RB
shorter/JJR
than/IN
3/CD
’/NN
UTR/NN
./.
====================
Consequently/RB
,/,
the/DT
ratio/NN
of/IN
the/DT
Alu/NN
insertion/NN
was/VBD
very/RB
low/JJ
./.
====================
Therefore/RB
,/,
we/PRP
used/VBD
Alu/FW
at/IN
3/CD
’/NN
UTR/NN
only/RB
./.
====================
Here/RB
,/,
we/PRP
put/VBP
forward/IN
a/DT
hypothesis/NN
that/IN
Alu/NN
is/VBZ
another/DT
important/JJ
factor/NN
that/WDT
enhances/VBZ
the/DT
conversion/NN
of/IN
an/DT
mRNA/NN
to/TO
a/DT
processed/VBN
pseudogene/NN
./.
====================
An/DT
mRNA/NN
with/IN
Alu/NN
element/NN
at/IN
3/CD
’/NN
UTR/NN
has/VBZ
1.53/CD
times/NNS
higher/JJR
likelihood/NN
of/IN
becoming/VBG
a/DT
pseudogene/NN
./.
====================
